Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vadim Markovtsov

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Methods in Enzymology|January 10, 2004
Strategies and methods of cross-linking of RNA polymerase active centerArkadv Mustaev, Eugeny Zaychikov, Mikhail Grachev, et al.
Bioorganic & Medicinal Chemistry|August 16, 2022
Structure activity relationships leading to the identification of the indirect activator of AMPK, R419Simon J Shaw, Dane A Goff, David C Carroll, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Tuning the Reactivity of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Optimal <i>in Vivo</i> EfficacyVadim Markovtsov, Matthew A J Duncton, Art Bagos, et al.
American Journal of Hematology|April 27, 2018
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trialsJames Bussel, Donald M Arnold, Elliot Grossbard, et al.
Molecular Biology of the Cell|October 1, 2005
Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growthYonchu Jenkins, Vadim Markovtsov, Wayne Lang, et al.
Blood|May 3, 2011
R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasmKotaro Shide, Takuro Kameda, Vadim Markovtsov, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 25, 2014
Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed miceKristen A Baltgalvis, Kathy White, Wei Li, et al.
Journal of Cancer Research and Clinical Oncology|July 18, 2009
Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screenJohn McLaughlin, Vadim Markovtsov, Hui Li, et al.
Plos One|December 17, 2013
AMPK activation through mitochondrial regulation results in increased substrate oxidation and improved metabolic parameters in models of diabetesYonchu Jenkins, Tian-Qiang Sun, Vadim Markovtsov, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Methods in Enzymology|January 10, 2004
Strategies and methods of cross-linking of RNA polymerase active centerArkadv Mustaev, Eugeny Zaychikov, Mikhail Grachev, et al.
Bioorganic & Medicinal Chemistry|August 16, 2022
Structure activity relationships leading to the identification of the indirect activator of AMPK, R419Simon J Shaw, Dane A Goff, David C Carroll, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Tuning the Reactivity of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Optimal <i>in Vivo</i> EfficacyVadim Markovtsov, Matthew A J Duncton, Art Bagos, et al.
American Journal of Hematology|April 27, 2018
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trialsJames Bussel, Donald M Arnold, Elliot Grossbard, et al.
Molecular Biology of the Cell|October 1, 2005
Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growthYonchu Jenkins, Vadim Markovtsov, Wayne Lang, et al.
Blood|May 3, 2011
R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasmKotaro Shide, Takuro Kameda, Vadim Markovtsov, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 25, 2014
Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed miceKristen A Baltgalvis, Kathy White, Wei Li, et al.
Journal of Cancer Research and Clinical Oncology|July 18, 2009
Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screenJohn McLaughlin, Vadim Markovtsov, Hui Li, et al.
Plos One|December 17, 2013
AMPK activation through mitochondrial regulation results in increased substrate oxidation and improved metabolic parameters in models of diabetesYonchu Jenkins, Tian-Qiang Sun, Vadim Markovtsov, et al.
Pageof 2